Dr Hoenle AG (XTER:HNL) ROCE % : -2.19% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dr Hoenle AG's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.19%.

Dr Hoenle AG ROCE % Historical Data

The historical data trend for Dr Hoenle AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG ROCE % Chart

Dr Hoenle AG Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

Get a 7-Day Free Trial

15.44

5.64

0.29

3.72

-6.36

Dr Hoenle AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															6.72	3.69	-27.63	-6.83	-2.19

Dr Hoenle AG ROCE % Calculation

Dr Hoenle AG's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	-9.165	/	( ( (195.462 - 51.018)	+	(176.156 - 32.247) )	/ 2 )
	=	-9.165	/	( (144.444	+	143.909)	/ 2 )
	=	-9.165	/	144.1765
	=	-6.36 %

Dr Hoenle AG's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-3.108	/	( ( (176.156 - 32.247)	+	(168.032 - 28.339) )	/ 2 )
	=	-3.108	/	( ( 143.909	+	139.693 )	/ 2 )
	=	-3.108	/	141.801
	=	-2.19 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Dr Hoenle AG (XTER:HNL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dr Hoenle AG ROCE % Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Hoenle AG (XTER:HNL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HNL:Germany HNL:Germany

Address

Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205

Website

https://www.hoenle.de

Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines